异动解读 | 流感高发期带动抗流感药物需求 山东新华制药股份盘中大涨5.51%

异动解读
06 Jan

山东新华制药股份(00719)今日盘中大涨5.51%,引发了市场的广泛关注。

消息面上,中国疾控中心的最新数据显示,目前流感病毒阳性率持续上升,其中99%以上为甲型流感病毒。全国多地疾控部门均发出提醒,呼吁公众做好个人防护,注意防范呼吸道传染病。随着流感感染人数增多,抗流感药物销量也持续增长。

作为全球重要的解热镇痛药物供应商,山东新华制药旗下拥有布洛芬、阿司匹林、五安系列等抗流感产品。在流感高发期,该公司抗流感药物的需求旺盛,有望获益于当前的流感流行高峰,这也是其股价今日大涨的主要原因。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10